Publication | Closed Access

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

Node-positive Breast CancerBreast OncologyMedicinePharmacologyClinical TrialsAdjuvant TreatmentBreast CancerPharmacotherapyCancer TreatmentOncologyLong-term Outcomes